• Dupixent improves eczema severity in adolescents

    10 monthes ago - By Healio

    Findings from a phase 3 clinical trial support the use of weight-based Dupixent dosing in adolescents with moderate to severe atopic dermatitis.
    “To our knowledge, this trial is the largest to date of a systemic treatment for pediatric atopic dermatitis and the first confirmatory trial showing a favorable benefit-to-risk profile of a monoclonal antibody in this patient population with high unmet medical need,” Eric L. Simpson, MD, of the department of dermatology at Oregon Health & Science University, and colleagues wrote.
    A total of 251 patients were randomly assigned into
    Read more ...